Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

One growth stock I’d buy ahead of Astrazeneca plc

| Paul Summers

If dividends aren't a priority, Paul Summers think this top growth stock might be a better bet than Astrazeneca plc…

Read more »

Investing Articles

AstraZeneca plc isn’t the only pharma star that could make you rich

| Royston Wild

AstraZeneca plc (LON: AZN) isn't the only pharma giant that could make you rich. Here Royston Wild looks at another…

Read more »

Investing Articles

Why I’d ditch this defensive dividend stock to buy AstraZeneca plc

| G A Chester

G A Chester argues AstraZeneca plc (LON:AZN) is the pick of two defensive dividend stocks.

Read more »

Investing Articles

This small-cap stock could be a better dividend buy than AstraZeneca plc

| Jack Tang

Dividend investing: should you buy AstraZeneca plc (LON:AZN) after a setback in its ‘Mystic’ clinical trial, or consider this small-cap…

Read more »

Investing Articles

Why AstraZeneca plc could have a major impact on your investment performance

| Peter Stephens

AstraZeneca plc (LON: AZN) could be about to deliver vastly-improved financial performance.

Read more »

Investing Articles

One super dividend stock I’d buy along with AstraZeneca plc

| Kevin Godbold

This firm’s impressive finances make it a serious potential pairing in my portfolio with AstraZeneca plc (LON: AZN).

Read more »

Investing Articles

Why this dividend growth stock could be a better buy than AstraZeneca plc

| Roland Head

Roland Head explains why he's not buying AstraZeneca plc (LON:AZN) today.

Read more »

Investing Articles

Why I’m not buying FTSE 100 giants AstraZeneca plc and Barclays plc for their dividends

| Edward Sheldon, CFA

Edward Sheldon looks at drugs giant AstraZeneca plc (LON: AZN) and banking behemoth Barclays plc (LON: BARC) and explains why…

Read more »

Investing Articles

Top stocks for August

| The Motley Fool Staff

We asked our analysts to share their top stock picks for the coming month.

Read more »

Investing Articles

AstraZeneca plc’s shock plunge is a buying opportunity for the brave

| Harvey Jones

This could be the moment to buy AstraZeneca plc (LON: AZN) that you have been waiting for, says Harvey Jones.

Read more »

Investing Articles

Is AstraZeneca plc a falling knife to catch after dropping 15% today?

| Alan Oscroft

AstraZeneca plc (LON: AZN) could be one of best bargains of the FTSE 100 (INDEXFTSE: UKX) right now.

Read more »

Investing Articles

Why I’m considering FTSE 100 income and growth champion AstraZeneca plc

| Rupert Hargreaves

AstraZeneca plc (LSE: AZN) looks attractive to me today.

Read more »